These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

626 related items for PubMed ID: 26162684

  • 1. Relative efficacy and safety of tacrolimus, mycophenolate mofetil, and cyclophosphamide as induction therapy for lupus nephritis: a Bayesian network meta-analysis of randomized controlled trials.
    Lee YH, Song GG.
    Lupus; 2015 Dec; 24(14):1520-8. PubMed ID: 26162684
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of treatment response and serious infection using tacrolimus, tacrolimus with mycophenolate mofetil, in comparison to cyclophosphamide as induction treatment for lupus nephritis.
    Song GG, Lee YH.
    Int J Clin Pharmacol Ther; 2020 Oct; 58(10):550-556. PubMed ID: 32691727
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative efficacy and safety of low-dose and high-dose cyclophosphamide as induction therapy for lupus nephritis: a network meta-analysis.
    Bae SC, Lee YH.
    Z Rheumatol; 2019 Jun; 78(5):467-473. PubMed ID: 30039177
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Multitarget therapy versus monotherapy as induction treatment for lupus nephritis: A meta-analysis of randomized controlled trials.
    Lee YH, Song GG.
    Lupus; 2022 Oct; 31(12):1468-1476. PubMed ID: 35986446
    [Abstract] [Full Text] [Related]

  • 10. Induction and maintenance therapy for lupus nephritis: a systematic review and meta-analysis.
    Lee YH, Woo JH, Choi SJ, Ji JD, Song GG.
    Lupus; 2010 May; 19(6):703-10. PubMed ID: 20064907
    [Abstract] [Full Text] [Related]

  • 11. Immunosuppressive treatment for proliferative lupus nephritis.
    Tunnicliffe DJ, Palmer SC, Henderson L, Masson P, Craig JC, Tong A, Singh-Grewal D, Flanc RS, Roberts MA, Webster AC, Strippoli GF.
    Cochrane Database Syst Rev; 2018 Jun 29; 6(6):CD002922. PubMed ID: 29957821
    [Abstract] [Full Text] [Related]

  • 12. Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis.
    Rathi M, Goyal A, Jaryal A, Sharma A, Gupta PK, Ramachandran R, Kumar V, Kohli HS, Sakhuja V, Jha V, Gupta KL.
    Kidney Int; 2016 Jan 29; 89(1):235-42. PubMed ID: 26489028
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immunosuppressive therapies for the induction treatment of proliferative lupus nephritis: a systematic review and network metaanalysis.
    Tian SY, Feldman BM, Beyene J, Brown PE, Uleryk EM, Silverman ED.
    J Rheumatol; 2014 Oct 29; 41(10):1998-2007. PubMed ID: 25225281
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Relative efficacy and safety of calcineurin inhibitor, mycophenolate mofetil, and azathioprine as maintenance therapies for lupus nephritis: a network meta-analysis.
    Lee YH, Song GG.
    Z Rheumatol; 2024 Feb 29; 83(Suppl 1):140-147. PubMed ID: 37278824
    [Abstract] [Full Text] [Related]

  • 18. Comparative efficacy and safety of rituximab, mycophenolate, and cyclophosphamide in active antineutrophil cytoplasmic antibody-associated vasculitis: A Bayesian network meta-analysis of randomized controlled trials.
    Lee YH, Song GG.
    Int J Clin Pharmacol Ther; 2021 Oct 29; 59(10):645-653. PubMed ID: 34338191
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and adverse events of mycophenolate mofetil versus cyclophosphamide for induction therapy of lupus nephritis: systematic review and meta-analysis.
    Kamanamool N, McEvoy M, Attia J, Ingsathit A, Ngamjanyaporn P, Thakkinstian A.
    Medicine (Baltimore); 2010 Jul 29; 89(4):227-235. PubMed ID: 20616662
    [Abstract] [Full Text] [Related]

  • 20. Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial.
    Kamanamool N, Ingsathit A, Rattanasiri S, Ngamjanyaporn P, Kasitanont N, Chawanasuntorapoj R, Pichaiwong W, Anutrakulchai S, Sangthawan P, Ophascharoensuk V, Avihingsanon Y, Sumethkul V.
    Lupus; 2018 Apr 29; 27(4):647-656. PubMed ID: 29105558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.